Category Archives: FDA Stem Cell Trials

02-02-2012 11:09 Good Morning, It’s Thursday February 2nd, 2012, I’m Christina Collins with CRWENewswire Stocks In Action StemCells Incorporated – symbol STEM – reported that the FDA has authorized the initiation of a Phase I/II clinical trial of the Company’s proprietary HuCNS-SC product candidate (purified human neural stem cells) in dry age-related macular degeneration On its first quarter fiscal 2012, Green Mountain Coffee Roasters Incorporated – symbol GMCR – posted GAAP operating income of $145.8 million, compared to $23.3 million in the same period the prior year and lastly; Discovery Laboratories Incorporated – symbol DSCO – reported that AFECTAIR is now registered with the FDA and is cleared to be marketed in the United States. AFECTAIR is a proprietary patient interface technology that simplifies delivery of aerosolized medications to patients requiring ventilator support. Thank you for joining me andhave a great day! For CRWE Newswire, Stocks In Action, I’m Christina Collins ********************************* THIS IS NOT A RECOMMENDATION TO BUY OR SELL ANY SECURITY! Disclaimer: Never invest in any stock featured on our site or emails unless you can afford to lose your entire investment Continue reading →